Cargando…
The burden of RSV-associated illness in children aged < 5 years, South Africa, 2011 to 2016
BACKGROUND: Vaccines and monoclonal antibodies to protect the very young infant against the respiratory syncytial virus (RSV)-associated illness are effective for limited time periods. We aimed to estimate age-specific burden to guide implementation strategies and cost-effectiveness analyses. METHOD...
Autores principales: | Moyes, Jocelyn, Tempia, Stefano, Walaza, Sibongile, McMorrow, Meredith L., Treurnicht, Florette, Wolter, Nicole, von Gottberg, Anne, Kahn, Kathleen, Cohen, Adam L., Dawood, Halima, Variava, Ebrahim, Cohen, Cheryl |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10088270/ https://www.ncbi.nlm.nih.gov/pubmed/37038125 http://dx.doi.org/10.1186/s12916-023-02853-3 |
Ejemplares similares
-
The economic burden of RSV-associated illness in children aged < 5 years, South Africa 2011–2016
por: Moyes, Jocelyn, et al.
Publicado: (2023) -
The national burden of influenza‐like illness and severe respiratory illness overall and associated with nine respiratory viruses in South Africa, 2013–2015
por: Tempia, Stefano, et al.
Publicado: (2022) -
Health and economic burden of influenza‐associated illness in South Africa, 2013‐2015
por: Tempia, Stefano, et al.
Publicado: (2019) -
The Impact of Influenza and Tuberculosis Interaction on Mortality Among Individuals Aged ≥15 Years Hospitalized With Severe Respiratory Illness in South Africa, 2010–2016
por: Walaza, Sibongile, et al.
Publicado: (2019) -
Human bocavirus, coronavirus, and polyomavirus detected among patients hospitalised with severe acute respiratory illness in South Africa, 2012 to 2013
por: Subramoney, Kathleen, et al.
Publicado: (2018)